(Q46512890)

22 December 2017

title

Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation (English)

1 reference

22 December 2017

1 reference

liver transplantation

1 reference

1 reference

1 reference

Forgacs B

1

1 reference

22 December 2017

Merhav HJ

series ordinal

2

1 reference

22 December 2017

Lappin J

series ordinal

3

1 reference

22 December 2017

Mieles L

series ordinal

4

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

22 December 2017

Transplantation Proceedings

published in

1 reference

22 December 2017

volume

37

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

1912-1914

1 reference

22 December 2017

Neurotoxicity of immunosuppressive drugs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.02.101

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.02.101

Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.02.101

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.02.101

Sirolimus: a potent new immunosuppressant for liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.02.101

FK506-induced neurotoxicity in liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.02.101

Sirolimus improves the two-year outcome of renal allografts in African-American patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.02.101

Impact of sirolimus on renal transplant outcomes in African Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.02.101

Sirolimus in liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.02.101

Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.02.101

10.1016/J.TRANSPROCEED.2005.02.101

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017